BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-419@pharmaconomics
DTSTAMP:20260707T042256Z
DTSTART;VALUE=DATE:20260330
DTEND;VALUE=DATE:20260331
SUMMARY:AQST AdCom — Anaphylm
DESCRIPTION:An FDA advisory committee reviews Anaphylm for Type I allergic reactions\, including anaphylaxis around Mar 30\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000022/aqst-20260330.htm\n\nTrack it: https://pharmaconomics.com/e/419
URL:https://pharmaconomics.com/e/419
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AQST catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR